Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
BJU International|January 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|June 18, 2024
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, et al.
Communications Biology|July 28, 2023
Identification of genotype-biochemical phenotype correlations associated with fructose 1,6-bisphosphatase deficiencyIkki Sakuma, Hidekazu Nagano, Naoko Hashimoto, et al.
Scientific Reports|March 31, 2024
Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomyYuta Yamada, Yoichi Fujii, Shigenori Kakutani, et al.
Haematologica|May 23, 2020
A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemiaHiroki Mizumaki, Kazuyoshi Hosomichi, Kohei Hosokawa, et al.
International Journal of Clinical Oncology|March 3, 2025
The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched studySatoru Taguchi, Taketo Kawai, Yoshiaki Kurokawa, et al.
Japanese Journal of Clinical Oncology|January 15, 2025
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinomaTaketo Kawai, Yoshiaki Kurokawa, Satoru Taguchi, et al.
Communications Biology|October 1, 2020
Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targetsYasuo Kubota, Masafumi Seki, Tomoko Kawai, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinomaYoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, et al.
Oncogene|November 2, 2022
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolismKentaro Watanabe, Shunsuke Kimura, Masafumi Seki, et al.
Pageof 6